Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

Generative AI has largely escaped the U.S. FDA’s regulatory purview up to now, but OpenAI seems poised to create a new source of regulatory angst for the agency. The company unveiled its ChatGPT ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Canadian International School will host the 11th edition of its Juniors Golf Tournament for students. Choose from any one of ...

An illustration of lipid nanoparticles (green circles) targeting the lung, designed using neural networks. Witten et al. present a method (LiON) using neural networks for lipid discovery and ...

DBS Private Bank is giving clients new and exclusive ways to strengthen returns as markets become more volatile and traditional allocations lose their edge. For decades, many investors relied on the ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during the week ended December 19, while cutting positions in consumer technology ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...

A glut of space paired with a lack of demand has plagued the life sciences real estate market, and developers are banking on the rise of artificial intelligence to be their cure. New technologies are ...

Ben Inker, GMO co-head of asset allocation, joins CNBC's 'Money Movers' to discuss AI bubble concerns, Japan's stock revolution and more. Pam Bondi needs an intervention Three Medicare coverage ...